Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone

NCT02265406 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT02265406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone
Lead sponsor
Poitiers University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2015
Completion date
July 25, 2020
Enrollment
354 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

early ventilation acquired pneumonia in brain injured patients